Related Experiment Video
Updated: Aug 24, 2025
04:38
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
Published on: March 28, 2018
15.8K
[Biliary sludge: pathogenesis, etiology and drug therapy]
I G Bakulin1, E B Avalueva1, M U Serkova1
1Mechnikov North-Western State Medical University.
Terapevticheskii Arkhiv
|October 26, 2022
Summary
Ursodeoxycholic acid (UDCA) effectively treats biliary sludge (BS), with the German brand Ursofalk showing superior results compared to generic UDCA. Ursofalk significantly improved sludge resolution and gallbladder function within three months.
Area of Science:
- Gastroenterology
- Hepatology
- Pharmacology
Context:
- Biliary sludge (BS) affects a significant patient population, necessitating effective treatment options.
- Ursodeoxycholic acid (UDCA) is a primary medical treatment for BS.
- Assessing the comparative efficacy of branded versus generic UDCA is crucial for clinical practice.
Purpose:
- To evaluate the effectiveness of ursodeoxycholic acid (UDCA) in treating biliary sludge (BS).
- To compare the therapeutic efficacy of a German-manufactured UDCA (Ursofalk) against generic UDCA formulations.
- To assess the impact of UDCA on gallbladder contractility.
Summary:
- A randomized study of 65 BS patients compared Ursofalk (Germany) with generic UDCA.
- After 3 months, Ursofalk achieved 87.1% sludge dissolution versus 50% for generics, with improved gallbladder function.
- At 6 months, Ursofalk showed 93.5% resolution compared to 73.6% for generics.
Impact:
- Ursofalk demonstrates high effectiveness in oral litolysis for stage I biliary sludge.
- Early treatment with Ursofalk (within 3 months) leads to significant sludge resolution and normalized gallbladder contractility.
- The study supports the use of Ursofalk for improved patient outcomes in biliary sludge management.
Related Concept Videos
01:16Hepatic Drug Excretion: Influencing Factors
189
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
189
01:17Hepatic Drug Excretion: Enterohepatic Cycling
1.7K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.7K
01:26Diseases of the Liver and Gallbladder
881
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
881
01:14Hepatic Drug Clearance: Role of Transporters
94
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
94
01:29Chronic Pancreatitis II: Collaborative Care
123
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
123
01:16Drug Biotransformation: Overview
2.5K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.5K